Adv. Shai Baranov and ***** from the International Department accompanied biomed company BiomX in raising $ 24 million in the first financing round.
BiomX, formerly MBCure, was founded in Futurx Technology Incubator. It develops innovative drugs to treat a variety of diseases caused by microbial imbalance.
The funds will be used to advance the Company's pharmaceutical research towards the development of human clinical trials and the continuation of technological development.